x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Pharmaceutical Executive

Pharmaceutical Executive Podcast

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.

science life sciences

All Episodes

00:14:08

Episode 77: The Effects of AI on IP

Pharmaceutical Executive ·

2021/03/04

Kevin Buckley, founder of Torrey Pines Law Group, and Neil Thompson, a patent agent with the firm, discuss IP strategy as it relates to pharma and artificial intelligence.

en-us

00:15:27

Episode 76: Repatriating Pharma

Pharmaceutical Executive ·

2021/02/18

Joel Marcus, founder and executive chairman of Alexandria Real Estate Equities, and founder and CEO of Alexandria Venture Investments, discusses the drive to bring pharma manufacturing back to a company’s home country and the issues involved in doing so.

en-us

00:32:30

Episode 75: Protecting Pharma Through Cybersecurity

Pharmaceutical Executive ·

2021/02/04

Scott Nawrocki, managing director of digital investigations and cyber defense at Nardello & Co., discusses cybersecurity in pharma, including topics from prevention to crisis management.

en-us

00:24:58

Episode 74: 2021 Industry Outlook

Pharmaceutical Executive ·

2021/01/21

Editorial Director, Lisa Henderson; European and online editor, Julian Upton; Senior Editor, Elaine Quilici ;and Assistant Editors of Pharmaceutical Executive, Miranda Schmalfuhs and Andy Studna, discuss some exciting industry trends for 2021, which they recently wrote for the January issue.

en-us

00:11:15

Episode 73: Biotech’s IPO Steamroll

Pharmaceutical Executive ·

2021/01/07

Gregg Beloff, co-founder of Danforth Advisors, discusses the banner year biotech IPOs had in 2020, the drive behind that boom, and what the future of industry IPOs might look like

en-us

00:21:51

Episode 72: Trying to Outpace Rare Disease

Pharmaceutical Executive ·

2020/12/24

Rich Horgan, founder and president of Cure Rare Disease(CRD), discusses how he sprang into action when his brother was diagnosed with Duchenne muscular dystrophy, by starting a nonprofit biotech to help find a cure.

en-us

00:12:51

Episode 71: Connecting With NPs and PAs

Pharmaceutical Executive ·

2020/12/10

Sacha Ward, chief client officer of Point of Care Network, discusses how COVID has affected the roles of nurse practitioners and physician assistants, and why marketing managers should take a moment to understand this growing group of health care influencers.

en-us

00:13:19

Episode 70: Keeping Pharma Informed

Pharmaceutical Executive ·

2020/11/26

Krystle Buntemeyer, president of SCORR Marketing, and Bharat Mehta, co-founder of PharmaCompass, discuss a new, free online tool called Pipeline Prospector, which they recently launched in collaboration. The tool aims to provide pharma executives with industry data, including deal and pipeline information, to help them make more informed decisions.

en-us

00:08:36

Episode 69: Fighting Influenza During COVID

Pharmaceutical Executive ·

2020/11/12

Dr. Gregg Sylvester, chief medical officer of Seqirus, discusses the importance of vaccinating against the seasonal flu amid the COVID pandemic, and how the two viruses should be considered in light of each other.

en-us

00:23:01

Episode 68: Rocking Garage Biotech

Pharmaceutical Executive ·

2020/10/29

Panna Sharma, CEO of Lantern Pharma, discusses garage biotech, what he’s learned from the culture, and how it might help transform certain areas of pharma, including innovation and pricing.

en-us

00:11:06

Episode 67: Succeeding Through Adversity

Pharmaceutical Executive ·

2020/10/15

Sanjeev Luther, president and CEO of Rafael Pharmaceuticals, discusses how he managed to turn around a company on the brink of bankruptcy and advance clinical trials for its lead cancer drug through COVID-19.

en-us

00:18:13

Episode 66: New Approach to Antithrombotics

Pharmaceutical Executive ·

2020/10/01

Dr. Neil Hayward, CEO and founder of eXlthera, is here to discuss his company, which is developing Factor XI inhibitor antithrombotics that are attacking blood clots from a new angle and are giving patients new hope.

en-us

00:15:26

Episode 65: Creating a Path for Innovation

Pharmaceutical Executive ·

2020/09/17

George Baxter, CEO of Edinburgh Innovations, is here to discuss the company's commercialization model, and how his group is bringing innovation to market in Scotland.

en-us

00:16:22

Episode 64: The Complexities of Managing ADHD

Pharmaceutical Executive ·

2020/09/03

Jack Khattar, president and CEO of Supernus Pharmaceuticals, talks about his experience bringing ADHD drugs to market in a challenging environment.

en-us

00:16:54

Episode 63: Three Simple Principles to Improve...

Pharmaceutical Executive ·

2020/08/20

Eric Turbiville, author of the recently published book “The Perfect Leadership Triad: How Top Executives Maximize Productivity through People, Coaching, and Performance," a 25-year pharma veteran, credentialed executive coach, and director of mentoring for the Southwest region of the Healthcare Businesswomen’s Association says there are three leadership principles can help executives through tumultuous times, and is here to discuss how they can impact success.

en-us

00:18:37

Episode 62: The Future of Pharma’s Supply Chain

Pharmaceutical Executive ·

2020/08/06

Kurt Orlofski, CEO of Pharmaceutical Associates Inc., discusses what the pharmaceutical supply chain might look like post COVID-19, and how companies can prepare for that.

en-us

00:17:08

Episode 61: Preparing for Virtual High-Stakes Meetings

Pharmaceutical Executive ·

2020/07/23

Jim and Cindy DiBiasi, co-founders of 3D Communications, talk about how to prepare for virtual high-level meetings, such as important regulatory presentations and keynote addresses, in the wake of COVID-19.

en-us

00:14:03

Episode 60: Leading With Compassion

Pharmaceutical Executive ·

2020/07/09

Tim Walbert, CEO of Horizon Therapeutics, shares his unique perspective on managing the Chicago location of the company through COVID-19, in light of the fact that he himself is immunocompromised.

en-us

00:15:30

Episode 59: Using Tau to Target Alzheimer’s

Pharmaceutical Executive ·

2020/06/25

Janice Kranz, co-founder of Eikonizo Therapeutics, bring us up to date on how targeting tau to fight Alzheimer’s and other neurodegenerative diseases is making waves in the CNS space.

en-us

00:19:21

Episode 58: Understanding FDA’s Gene Therapy Guidelines

Pharmaceutical Executive ·

2020/06/11

Dr. Jonathan Gertler, CEO of Back Bay Life Science Advisors, and Dr. Stephan Gauldie, Managing Director of Back Bay, talk about the new guidelines set forth by FDA in regard to gene therapy, and what those new parameters mean for pharma and biotech.

en-us

337 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter